Phase 3 Study of Dexpramipexole in ALS (EMPOWER)

We noticed a lot of visitors searching the RASCALS site recently for information regarding Biogen Idec’s Dexpramipexole Phase 3 trials, (a.k.a. NCT01281189). The RASCALS staff will assuredly pass along any news articles and press releases we find.

Here are some other reliable links to follow:

ClinicalTrials.gov

World Health Organization (WHO)

PatientsLikeMe

PatientsLikeMe (KNS-760704)

# # #

The Robert A. Stehlin Campaign for ALS (R.A.S.C.A.L.S.) is an all-volunteer 501(c)(3) charity. 100% of all funds raised go to building awareness, treatment research and development, plus ALS family assistance. There are no administrative costs.

Contributions are tax-deductible.

You may also be interested in visiting the RASCALS Store.

The material presented here is for informational purposes only and should not be construed as medical advice, or relied upon as a substitute for medical advice from a health care provider.

 

Leave a Reply